SLN — Silence Therapeutics plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1479615 ·
United Kingdom
Last close
$6.64
Market Cap
$313.64M
52W High
$8.40
52W Low
$4.75
ADV30
306,150
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 422,000 | 411,000 | -15,737,000 | -14,957,000 | 115,123,000 | 5,657,000 | 65,721,000 |
| Dec 2025 | 34,000 | 22,000 | -12,461,000 | -11,770,000 | 131,442,000 | 11,277,000 | 69,138,000 |
| Sep 2025 | 159,000 | 95,000 | -26,244,000 | -20,958,000 | 146,790,000 | 82,031,000 | 72,727,000 |
| Jun 2025 | 224,000 | 139,000 | -22,639,000 | -27,354,000 | 165,233,000 | 41,739,000 | 71,078,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-62,271,000
Investing CF
$-47,992,000
Financing CF
$15,000
CapEx
$-110,768
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-562,572,000
Inventory
—
Receivables
$24,614,000
ST Investments
$73,837,000
EBIT TTM
$-89,753,000
Pretax Income TTM
$-88,601,000
Interest Exp TTM
$11,511,234
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$839,000
EBITDA
$-71,083,000
Free Cash Flow
$-44,562,752
Enterprise Value
$808,621,824
Total Cash
$70,078,000
Total Debt
$136,000
Shares Out
47,234,613
Trailing EPS
$-1.62
Book Value
$1.32
ROE
-92.6%
ROA
-29.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 559,000 | -89,753,000 | -88,612,000 | 131,442,000 | 69,138,000 | — | -62,271,000 |
| Dec 2024 | 43,258,000 | -63,319,000 | -45,309,000 | 202,635,000 | 68,612,000 | — | -67,640,000 |
| Dec 2023 | 31,643,000 | -64,383,000 | -54,228,000 | 119,448,000 | 97,455,000 | — | -49,462,000 |
| Dec 2022 | 21,655,000 | -61,040,000 | -50,334,000 | 130,096,453 | 103,384,928 | — | -57,044,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABEO | ABEONA THERAPEUTICS INC. | $312.90M | $5.49 | — |
| RZLT | Rezolute, Inc. | $317.76M | $3.30 | — |
| TENX | TENAX THERAPEUTICS, INC. | $317.77M | $11.98 | — |
| RCKT | ROCKET PHARMACEUTICALS, INC. | $327.58M | $3.00 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | $300.26M | $3.89 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-05-26 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
2026-05-22 15:06 · Yahoo
European Equities Traded in US as ADRs Rise in Wednesday Trading
2026-05-20 15:03 · Yahoo
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
2026-05-19 15:27 · Yahoo
European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading
2026-05-15 15:04 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading
2026-05-12 15:14 · Yahoo
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
2026-05-12 12:00 · Yahoo
This Silence Therapeutics Insider Increased Their Holding In The Last Year
2026-05-12 10:07 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
2026-05-11 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
2026-05-07 15:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.